PolyNovo Limited

A$0.89As of Sun 8 Nov 2026, 12:00 UTC
ASX:PNVHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 11.10%
Div yield —
ROE 8.44%
Medical Devices
Beta (5Y) 1.30
PE TTM 84.76
TSR TTM (32.58%)
Mkt cap A$614.9M
ROIC 17.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.916
2.89%
129.04%
Hold 1|4|7|3|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
4.90%
(0.57%)
(5.78%)
(4.59%)
Revenue$M
54.79
54.79
53.54
55.59
10.59%
5.81%
(1.82%)
(1.12%)
Peers (US$422.3M)
Cap (US$)
PE
43.77M
—
422.8M
—
Capital
TTM
5Y
10Y
Leveragex
12.07
0.288
0.260
EBIT/Intx
2.369
0.144
0.131
Own earn%
13.71
(127.27)
(126.68)
Sh yield%
45.58
26.65
26.82
Owners
Insiders/Inst%
7.97
76.42
Short interest%
5.07
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
4–12
$1 testx
0.0
Incr. ROIC%
6